Rare diseases
Investigational molecules
Locations
Study of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy
PolandStudy of Lurbinectedin and Atezolizumab for Maintenance Therapy in Patients with Extensive-Stage Small-Cell Lung Cancer
PolandStudy on Ravulizumab for Adults with Immunoglobulin A Nephropathy (IgAN) to Preserve Kidney Function
PolandStudy Comparing Pirtobrutinib with Idelalisib and Rituximab or Bendamustine and Rituximab for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
PolandStudy of inavolisib, palbociclib and fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer
PolandStudy of SEL120 Monohydrochloride for Treating Anemia in Patients with Lower-Risk Myelodysplastic Syndromes (MDS)
PolandStudy on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis
PolandStudy on the Effectiveness and Safety of Batoclimab for Adults with Generalized Myasthenia Gravis
PolandStudy on Atezolizumab and Drug Combinations for Advanced Malignancies in Patients from Previous Atezolizumab Trials
PolandStudy on the Effectiveness and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Children with Multiple Sclerosis
PolandStudy on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery
PolandStudy on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
